Carlsmed (CARL) Equity Ratio (2024 - 2026)

Carlsmed (CARL) has 3 years of Equity Ratio data on file, last reported at 0.78 in Q1 2026.

• For the quarter ending Q1 2026, Equity Ratio changed N/A year-over-year to 0.78; the trailing twelve-month figure through Mar 2026 stood at 0.78 (changed N/A YoY), and the FY2025 full-year result was 0.76, up 155.75% from the prior year.
• Equity Ratio for Q1 2026 stood at 0.78, up from 0.76 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.79 in Q3 2025 and bottomed at 1.56 in Q2 2025.
• The 3-year median for Equity Ratio is 0.76 (2025), against an average of 0.12.
• Peak annual rise in Equity Ratio reached 155.75% in 2025, while the deepest fall reached 155.75% in 2025.
• A 3-year view of Equity Ratio shows it stood at 1.36 in 2024, then soared by 155.75% to 0.76 in 2025, then increased by 2.22% to 0.78 in 2026.
• The last three Equity Ratio figures came in at 0.78 (Q1 2026), 0.76 (Q4 2025), and 0.79 (Q3 2025), per Business Quant data.

Peer Comparison